Thursday, December 3, 2020
Home Latest Pharma-News Due to Potential Battery Failure Getinge's Maquet / Datascope Recalls Cardiosave Hybrid,...

Due to Potential Battery Failure Getinge’s Maquet / Datascope Recalls Cardiosave Hybrid, Cardiosave Rescue, CS300 and CS100/100i Intra-Aortic Balloon Pumps (IABP)

Nov 19, 2019: USFDA provides an update on failure related to Getinge’s Maquet/Datascope intra-aortic balloon pump (IABP) devices (Cardiosave Hybrid and Cardiosave Rescue).

From the previous letter to health care providers, the FDA informed providers about the devices shutting down while running on battery power, leading to pump stop and loss of hemodynamic support.

- Advertisement -

FDA has received over 60 additional medical device reports related to this issue, including two patient deaths and one serious patient injury after the previous communication on November 1, 2018.

The FDA continues to work with the manufacturer to inspect and deal with the root cause of these IABP devices shutting down while running on battery power. At present Maquet/Datascope is developing a Cardiosave battery maintenance software upgrade.


Please enter your comment!
Please enter your name here

four × 4 =

Most Popular

FDA approves Xolair® (omalizumab) for adults with nasal polyps

December 01, 2020: "Roche announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA)...

UK authorises Pfizer/BioNTech COVID-19 vaccine

December 02, 2020: "A Department of Health and Social Care spokesperson said: The government has accepted the recommendation from...

WHO Releases COVID-19 App for Trusted and Timely Updates

 December 01, 2020: The WHO has published a new mobile app to centralize the most trusted updates about COVID-19, and to guide...